Globin Solutions
Pittsburgh, US · Founded 2017 · Delaware corporation
Founders & leadership
JJ
Jason J. RoseNamed on SEC filing
XW
Xueli WangNamed on SEC filing
MT
Mark T. GladwinNamed on SEC filing
JT
Jesus Tejero BravoNamed on SEC filing
Reported raises · per SEC filings
Form D private placements$4.5M disclosed across 1 round · 2017
▶$4.5MraisedJan 2018 · 1 investors · BiotechnologyRule 506(b)
▶$4.5MraisedJan 2018 · 1 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Jason J. RoseExecutive Officer, Director
- Xueli WangExecutive Officer, Director
- Mark T. GladwinDirector
- Jesus Tejero BravoExecutive Officer, Director
- Offering amount
- $8M
- Amount sold
- $4.5M
- Proceeds to insiders
- $10K
- First sale
- Dec 2017
- Incorporated
- Corporation, Delaware, 2017
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Non-dilutive funding · 2 SBIR/STTR awards
Federal grants — no equity taken| Agency | Phase | Year | Amount |
|---|---|---|---|
| National Institutes of Health (NIH)National Institutes of Health | Phase IISTTR | 2021 | $1.5M |
| National Institutes of Health (NIH)National Institutes of Health | Phase ISTTR | 2020 | $250K |
Source: SBIR.gov award data (U.S. Small Business Administration). SBIR/STTR awards are competitive federal R&D grants and contracts — non-dilutive capital alongside any venture rounds above.
Frequently asked questions
- How much funding has Globin Solutions raised?
- Globin Solutions has disclosed $4.5M raised across 1 round.
- Where is Globin Solutions headquartered?
- Globin Solutions is headquartered in Pittsburgh, US.